Aim­mune's peanut al­ler­gy im­munother­a­py clears Eu­ro­pean PhI­II with fly­ing col­ors, paving way for first US, EU ther­a­peu­tic ap­proval

Days af­ter the FDA fi­nal­ly ac­cept­ed the ap­pli­ca­tion to re­view its peanut al­ler­gy im­munother­a­py, Aim­mune laid out pos­i­tive piv­otal study da­ta from its Eu­ro­pean Phase …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER